6cbv: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "6cbv" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
==Crystal strutcure of BRIL bound to an affinity matured synthetic antibody.== | |||
<StructureSection load='6cbv' size='340' side='right' caption='[[6cbv]], [[Resolution|resolution]] 1.87Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[6cbv]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6CBV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6CBV FirstGlance]. <br> | |||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr> | |||
[[Category: | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6cbv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6cbv OCA], [http://pdbe.org/6cbv PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6cbv RCSB], [http://www.ebi.ac.uk/pdbsum/6cbv PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6cbv ProSAT]</span></td></tr> | ||
</table> | |||
== Function == | |||
[[http://www.uniprot.org/uniprot/C562_ECOLX C562_ECOLX]] Electron-transport protein of unknown function. | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Kossiakoff, A A]] | |||
[[Category: Mukherjee, S]] | |||
[[Category: Skrobek, B]] | |||
[[Category: 4-helix bundle]] | |||
[[Category: Fab fragment]] | |||
[[Category: Fusion protein]] | |||
[[Category: Fusion protein in complex with fab]] | |||
[[Category: Immune system]] | |||
[[Category: Synthetic antibody]] | |||
Revision as of 09:45, 13 February 2019
Crystal strutcure of BRIL bound to an affinity matured synthetic antibody.
| ||||||||||||
